[ivory-search id="184" title="Recordati AJAX Search Form"]

Contact Us

Headquarter

Safety Reporting

To report a side effect following the use of Recordati/Innova Pharma/Italchimici/Natural Point products, contact +39 02487871 (switchboard Recordati S.p.A.) or use the online form here

Investor Relations

Eugenia Litz
Vice President, Head of Investor Relations

Eugenia.Litz@recordati.com
+44 7824 394 750

 

Gianluca Saletta
Investor Relations Analyst
saletta.g@recordati.it
+39 3489794876

 

See more here